Alerts will be sent to your verified email
Verify Email
AUROLAB
|
Auro Laboratories
|
IndoAmerican Advance
|
Oxygenta Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
12.83 % | 0.31 % | 16.56 % |
|
5yr average Equity Multiplier
|
1.84 | 1.07 | -1.71 |
|
5yr Average Asset Turnover Ratio
|
0.8 | 0.15 | 1.26 |
|
5yr Avg Net Profit Margin
|
9.49 % | -36.65 % | -10.07 % |
|
Price to Book
|
3.99 | n/a | 0.0 |
|
P/E
|
58.83 | n/a | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
80.24 Days | 0.0 | -21.7 Days |
|
Inventory Days
|
56.39 Days | 0.0 | 80.38 Days |
|
Days Receivable
|
214.37 Days | 0.0 | 20.8 Days |
|
Days Payable
|
115.48 Days | 167.71 Days | 154.17 Days |
|
5yr Average Interest Coverage Ratio
|
10.53 | -55.68 | -3.16 |
|
5yr Avg ROCE
|
16.02 % | -12.15 % | -3.19 % |
|
5yr Avg Operating Profit Margin
|
15.11 % | -72.03 % | -9.3 % |
|
5 yr average Debt to Equity
|
0.48 | 0.0 | -1.91 |
|
5yr CAGR Net Profit
|
-23.84 % | n/a | n/a |
|
5yr Average Return on Assets
|
7.53 % | -11.02 % | -6.87 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
52.18 % | 0.97 % | 55.93 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.09 % | -17.4 % | 43.6 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | -0.04 % |
|
Auro Laboratories
|
IndoAmerican Advance
|
Oxygenta Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|